ADMA – Adma Biologics Inc
ADMA — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
10.68
Margin Of Safety %
14
Put/Call OI Ratio
0.29
EPS Next Q Diff
0.08
EPS Last/This Y
0.18
EPS This/Next Y
0.19
Price
9.88
Target Price
17
Analyst Recom
1.75
Performance Q
16.77
Upside
147.7%
Beta
0.79
Ticker: ADMA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | ADMA | 8.98 | 0.39 | 0.57 | 73005 |
| 2026-07-14 | ADMA | 8.86 | 0.39 | 11.77 | 73001 |
| 2026-07-15 | ADMA | 8.69 | 0.40 | 0.57 | 73413 |
| 2026-07-16 | ADMA | 8.81 | 0.40 | 0.82 | 73471 |
| 2026-07-17 | ADMA | 8.72 | 0.40 | 15.33 | 73495 |
| 2026-07-20 | ADMA | 8.76 | 0.32 | 0.22 | 67056 |
| 2026-07-21 | ADMA | 8.6 | 0.32 | 0.46 | 67477 |
| 2026-07-22 | ADMA | 8.38 | 0.32 | 0.20 | 67640 |
| 2026-07-23 | ADMA | 8.38 | 0.32 | 0.12 | 67690 |
| 2026-07-24 | ADMA | 8.28 | 0.32 | 0.02 | 67726 |
| 2026-07-27 | ADMA | 8.49 | 0.32 | 1.47 | 67808 |
| 2026-07-28 | ADMA | 8.78 | 0.32 | 0.20 | 68087 |
| 2026-07-29 | ADMA | 8.7 | 0.32 | 0.03 | 68109 |
| 2026-07-30 | ADMA | 8.68 | 0.32 | 0.00 | 68117 |
| 2026-07-31 | ADMA | 8.45 | 0.32 | 0.43 | 68131 |
| 2026-08-03 | ADMA | 8.74 | 0.32 | 0.02 | 68149 |
| 2026-08-04 | ADMA | 8.95 | 0.32 | 0.03 | 68541 |
| 2026-08-05 | ADMA | 9.29 | 0.31 | 0.12 | 69520 |
| 2026-08-07 | ADMA | 9.89 | 0.29 | 0.43 | 72470 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | ADMA | 8.97 | 19.5 | - | 0.81 |
| 2026-07-14 | ADMA | 8.87 | 19.5 | - | 0.81 |
| 2026-07-15 | ADMA | 8.69 | 19.5 | - | 0.81 |
| 2026-07-16 | ADMA | 8.81 | 19.5 | - | 0.81 |
| 2026-07-17 | ADMA | 8.72 | 12.6 | - | 0.80 |
| 2026-07-20 | ADMA | 8.75 | 12.6 | - | 0.80 |
| 2026-07-21 | ADMA | 8.60 | 12.6 | - | 0.80 |
| 2026-07-22 | ADMA | 8.38 | 12.6 | - | 0.80 |
| 2026-07-23 | ADMA | 8.38 | 12.6 | - | 0.80 |
| 2026-07-24 | ADMA | 8.28 | 12.6 | - | 0.80 |
| 2026-07-27 | ADMA | 8.48 | 12.6 | - | 0.80 |
| 2026-07-28 | ADMA | 8.79 | 12.6 | - | 0.80 |
| 2026-07-29 | ADMA | 8.70 | 12.6 | - | 0.80 |
| 2026-07-30 | ADMA | 8.67 | 12.6 | - | 0.80 |
| 2026-07-31 | ADMA | 8.45 | 12.6 | - | 0.80 |
| 2026-08-03 | ADMA | 8.73 | 12.6 | - | 0.80 |
| 2026-08-04 | ADMA | 8.73 | 12.6 | - | 0.80 |
| 2026-08-05 | ADMA | 9.27 | 12.6 | - | 0.80 |
| 2026-08-06 | ADMA | 10.06 | 12.6 | - | 0.80 |
| 2026-08-07 | ADMA | 9.88 | 23.7 | - | 0.80 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | ADMA | -0.10 | -4.75 | 10.76 |
| 2026-07-14 | ADMA | -0.10 | -4.75 | 10.76 |
| 2026-07-15 | ADMA | -0.10 | -4.75 | 10.76 |
| 2026-07-16 | ADMA | -0.10 | -4.75 | 10.76 |
| 2026-07-17 | ADMA | -0.10 | -4.75 | 10.76 |
| 2026-07-20 | ADMA | -0.10 | -5.37 | 10.76 |
| 2026-07-21 | ADMA | -0.10 | -5.37 | 10.76 |
| 2026-07-22 | ADMA | -0.10 | -5.37 | 10.76 |
| 2026-07-23 | ADMA | -0.10 | -5.37 | 10.76 |
| 2026-07-24 | ADMA | -0.10 | -5.37 | 10.76 |
| 2026-07-27 | ADMA | -0.10 | -5.78 | 10.67 |
| 2026-07-28 | ADMA | -0.10 | -5.78 | 10.67 |
| 2026-07-29 | ADMA | -0.10 | -5.78 | 10.67 |
| 2026-07-30 | ADMA | -0.10 | -5.78 | 10.67 |
| 2026-07-31 | ADMA | -0.10 | -5.78 | 10.67 |
| 2026-08-03 | ADMA | -0.10 | -5.85 | 10.68 |
| 2026-08-04 | ADMA | -0.10 | -5.85 | 10.68 |
| 2026-08-05 | ADMA | -0.10 | -5.85 | 10.68 |
| 2026-08-06 | ADMA | -0.10 | -5.85 | 10.68 |
| 2026-08-07 | ADMA | -0.10 | -5.85 | 10.68 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.16
Avg. EPS Est. Current Quarter
0.2
Avg. EPS Est. Next Quarter
0.24
Insider Transactions
-0.1
Institutional Transactions
-5.85
Beta
0.79
Average Sales Estimate Current Quarter
138
Average Sales Estimate Next Quarter
155
Fair Value
11.23
Quality Score
98
Growth Score
73
Sentiment Score
89
Actual DrawDown %
61.5
Max Drawdown 5-Year %
-69
Target Price
17
P/E
14.04
Forward P/E
10.49
PEG
0.47
P/S
4.32
P/B
5.46
P/Free Cash Flow
19.02
EPS
0.7
Average EPS Est. Cur. Y
0.8
EPS Next Y. (Est.)
0.99
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
32.98
Relative Volume
0.84
Return on Equity vs Sector %
14.1
Return on Equity vs Industry %
30.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
◆
ADMA
Healthcare
$9.89
Swing / Pullback
Buy the dip on strong trends
WATCH
RSI
68.2
Range 1M
78.7%
Sup Dist
1.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
21.4%
EPS NY
18.3%
52W%
20.2%
Long-Term Value
Quality companies, undervalued
STRONG
🟢 BUY
+143.6% upside
Upside
+143.6%
Quality
98
MoS
14%
ADMA — P/E HistoricalBiotechnology
ADMA Biologics IncSector: Healthcare
Industry: Biotechnology
Employees: 640
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
ADMA
Latest News
—
Caricamento notizie per ADMA…
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading